Clinical Trials Browser

Phase 2 × NIH × Herpes Zoster × Clear all

NCT03702231 2023-08-04

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Phase 2 Completed

116 enrolled 11 charts

LymphoidOther hematologic neoplasm

Herpes Simplex, Herpes Zoster, Leukemia, Lymphocytic, Chronic, B-Cell